Logo image
Curcumin for neuropsychiatric disorders: a review of in vitro, animal and human studies
Journal article   Peer reviewed

Curcumin for neuropsychiatric disorders: a review of in vitro, animal and human studies

A.L. Lopresti
Journal of Psychopharmacology, Vol.31(3), pp.287-302
2017
url
Link to Published Version *Subscription may be requiredView

Abstract

Turmeric has been used in traditional medicine for centuries to treat a range of ailments. Its primary active constituent curcumin, can influence an array of biological activities. Many of these, such as its anti-inflammatory, antioxidant, neuroprotective, and monoaminergic effects are dysregulated in several neuropsychiatric disorders. In this systematic review, in vitro, animal, and human studies investigating the potential of curcumin as a treatment for neuropsychiatric disorders such as major depressive disorder, post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), bipolar disorder, psychotic disorders, and autism are reviewed, and directions for future research are proposed. It is concluded that curcumin is a promising, natural agent for many of these conditions, however, further research utilising robust, clinical designs are essential. The problem associated with the poor oral bioavailability of standard curcumin also requires consideration. Currently the greatest support for the efficacy of curcumin is for the treatment of major depressive disorder.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
3 Agriculture, Environment & Ecology
3.16 Phytochemicals
3.16.1399 Curcumin
Web Of Science research areas
Clinical Neurology
Neurosciences
Pharmacology & Pharmacy
Psychiatry
ESI research areas
Neuroscience & Behavior
Logo image